|
Neurodegenerative disorders linked to higher brain acidity
|
|
2
|
97
|
March 27, 2024
|
|
Insomnia and aggression in stable schizophrenic patients: The mediating role of quality of life
|
|
1
|
77
|
March 27, 2024
|
|
Reviva brilaroxazine presentation March 2024
|
|
6
|
168
|
March 27, 2024
|
|
Uk ranked worst for mental health behind Uzbekistan
|
|
4
|
144
|
March 26, 2024
|
|
The Cannabis-Schizophrenia Link Grows Stronger
|
|
10
|
175
|
March 26, 2024
|
|
Living with Schizophrenia: Beyond the Stigma (Audio & Video)
|
|
0
|
65
|
March 26, 2024
|
|
Olanzapine-Samidorphan for Schizophrenia: A Systematic Review and Meta-Analysis
|
|
4
|
104
|
March 25, 2024
|
|
Intensive Longitudinal Social Sensing in Patients With Psychosis Spectrum
|
|
0
|
65
|
March 25, 2024
|
|
bioXcelerate launches breakthrough AI tool for faster drug discovery
|
|
0
|
87
|
March 24, 2024
|
|
TMS Promising for Psychomotor Slowing in Schizophrenia
|
|
0
|
68
|
March 24, 2024
|
|
Promoting safer and wider worldwide use of clozapine
|
|
5
|
151
|
March 24, 2024
|
|
AI Maps Brain Tissues to Disease Symptoms - Neuroscience News
|
|
0
|
79
|
March 23, 2024
|
|
The effect of online group based acceptance and commitment therapy on psychotic symptoms and functioning levels of individuals with early psychosis
|
|
0
|
61
|
March 23, 2024
|
|
New treatments being developed for schizophrenia
|
|
0
|
133
|
March 22, 2024
|
|
Newron Pharmaceuticals - Evenamide set for a pivotal year - Edison Investment
|
|
0
|
100
|
March 22, 2024
|
|
A subtype of schizophrenia patients with altered methylation level of genes related to immune cell activity
|
|
0
|
64
|
March 22, 2024
|
|
Scientists elucidate the role of GlyT1 in anti-schizophrenia drugs
|
|
2
|
120
|
March 22, 2024
|
|
Discovery hints at genetic basis for the most challenging symptoms of schizophrenia
|
|
1
|
281
|
March 22, 2024
|
|
Five-week music therapy improves overall symptoms in schizophrenia by modulating theta and gamma oscillations
|
|
1
|
82
|
March 20, 2024
|
|
The impact of aerobic endurance training on cognitive performance in schizophrenic inpatients in a clinical routine setting
|
|
0
|
57
|
March 19, 2024
|
|
Bristol Myers completed the acquisition of the Karuna Therapeutics laboratory
|
|
12
|
213
|
March 19, 2024
|
|
Anavex begins Phase II trial of treatment for schizophrenia
|
|
1
|
103
|
March 19, 2024
|
|
Natural selection: Estrogen’s potential as a treatment for schizophrenia
|
|
0
|
73
|
March 19, 2024
|
|
Natural selection: Estrogen’s potential as a treatment for schizophrenia
|
|
5
|
100
|
March 19, 2024
|
|
It could take over 60 years to set up enough early intervention psychosis teams, TD warns (Ireland)
|
|
0
|
68
|
March 18, 2024
|
|
Relapse risk: Schizophrenia meds in supply crunch
|
|
0
|
98
|
March 18, 2024
|
|
Preliminary: group karaoke reduces paranoia (by Phil Corlett on Twitter)
|
|
2
|
91
|
March 18, 2024
|
|
Can Turmeric Help Treat or Prevent Schizophrenia?
|
|
6
|
152
|
March 17, 2024
|
|
The causal relationship between severe mental illness and risk of lung carcinoma
|
|
4
|
92
|
March 16, 2024
|
|
Real-World Evidence of Antipsychotic Monotherapy Versus Polypharmacy in the Treatment of Schizophrenia Spectrum Disorders
|
|
0
|
78
|
March 15, 2024
|